What is the appropriate dose of polyethylene glycol 3350 (MiraLAX) for a 21‑month‑old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MiraLAX Dosing for a 21-Month-Old Child

For a 21-month-old child with constipation, start with 0.8 g/kg/day of polyethylene glycol 3350 (PEG 3350), adjusting the dose to achieve 1-2 soft, painless stools daily.

Dosing Algorithm

Initial Dose

  • Start at 0.8-1.0 g/kg/day mixed in 4-8 ounces of any beverage 1, 2
  • For a typical 21-month-old weighing approximately 11-12 kg, this translates to roughly 9-12 grams daily (approximately 2-2.5 level teaspoons, as each level teaspoon contains ~3.3 grams) 3

Dose Titration

  • Adjust every 3 days based on response 4
  • Goal: 1-2 soft stools per day without pain or straining
  • If inadequate response: increase by 0.2-0.3 g/kg/day increments
  • If diarrhea develops: reduce dose immediately

Maintenance Dosing

The evidence shows that effective maintenance doses in children under 24 months range from 0.78-0.8 g/kg/day 1, 2. This is the target dose once constipation is relieved.

Evidence Quality and Rationale

While the FDA-approved adult dose is 17 grams daily 5, and the 2023 AGA/ACG guidelines strongly recommend PEG for chronic constipation 6, these guidelines focus on adults. For your 21-month-old patient, the pediatric research evidence is more applicable.

The most relevant studies for this age group demonstrate:

  • 97-97.6% efficacy in relieving constipation in children under 18-24 months 1, 2
  • Mean effective maintenance dose of 0.78-0.8 g/kg/day across multiple studies 1, 2
  • Excellent safety profile with only mild, transient adverse effects (primarily diarrhea that resolves with dose adjustment) 7, 1, 2

A 2020 systematic review specifically examining children under 24 months found dosage regimens ranging from 0.45-1.1 g/kg/day for PEG 3350, with no significant safety concerns 7.

Practical Measurement

Since the standard 17-gram capful is too large for this age:

  • Use measuring spoons: 1 level teaspoon ≈ 3.3 grams 3
  • For 9-10 grams: use approximately 3 level teaspoons
  • Level the dose with a straight edge for consistency 3
  • Mix in 4-6 ounces of any beverage (water, juice, milk)

Safety Considerations

Common pitfalls to avoid:

  • Don't use heaping measurements—these create excessive dose variability (up to 15 grams per tablespoon) 3
  • Don't continue the same dose if diarrhea develops—reduce immediately
  • Don't stop abruptly if effective—constipation often requires months of treatment (mean duration 6-11 months in studies) 1, 2

Monitoring:

  • Watch for transient diarrhea (occurs in ~13% but resolves with dose adjustment) 8
  • Mild bloating or gas may occur but typically doesn't require discontinuation 1, 2
  • No electrolyte monitoring is needed for PEG 3350 without electrolytes in otherwise healthy children 1, 2

Duration of Therapy

Studies show mean treatment duration of 6-11 months in this age group 1, 2. Long-term use appears safe and effective, with 91% success rates at long-term follow-up 1.

The evidence strongly supports PEG 3350 as first-line therapy for functional constipation in children as young as 1 month of age, with consistent efficacy and minimal adverse effects across all pediatric studies 7, 1, 2, 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.